自闭症相关PTCHD1-AS缺失导致人神经元突触功能障碍
研究利用3名携带PTCHD1-AS/PTCHD1等微缺失的自闭症谱系障碍(ASD)患者及对照者的诱导多能干细胞(iPSC)来源皮层神经元,发现ASD患者神经元微小兴奋性突触后电流频率降低且N-甲基-D-天冬氨酸(NMDA)受体功能低下。遗传学分析显示35个ASD相关缺失累及PTCHD1-AS外显子,外显子3缺失改变剪接而不影响邻近PTCHD1表达,且基因编辑该外显子可重现突触电流频率降低。结论提示PTCHD1-AS缺失是ASD风险因素并涉及兴奋性突触生理障碍。
要点
- ASD患者iPSC来源皮层神经元显示微小兴奋性突触后电流频率降低和NMDA受体功能低下。
- 35个ASD相关缺失映射到PTCHD1位点并破坏PTCHD1-AS外显子。
- PTCHD1-AS外显子3缺失改变剪接且不依赖PTCHD1表达,基因编辑可重现突触电流频率降低。
核心结论
- PTCHD1-AS缺失是自闭症谱系障碍的风险因素,其人iPSC来源神经元表现为兴奋性突触生理异常。
研究设计与样本
- 从不受影响的对照者和3名携带PTCHD1-AS/PTCHD1、PTCHD1-AS/DDX53或仅PTCHD1-AS微缺失的ASD患者生成iPSC。
- 用分子方法和电生理评估iPSC来源皮层神经元功能,并汇编PTCHD1位点遗传变异,用基因组编辑删除PTCHD1-AS单个保守外显子。
主要发现
- ASD患者iPSC来源神经元微小兴奋性突触后电流频率降低且NMDA受体功能低下。
- 35个ASD相关缺失映射到PTCHD1位点并破坏PTCHD1-AS外显子。
- 发现一个ASD相关的新发PTCHD1-AS外显子3缺失,外显子3丢失改变PTCHD1-AS剪接而不影响邻近PTCHD1编码基因表达。
- 靶向破坏PTCHD1-AS外显子3可重现微小兴奋性突触后电流频率降低。
关键数值与推荐
- 3名ASD患者分别携带影响PTCHD1-AS/PTCHD1、PTCHD1-AS/DDX53或仅PTCHD1-AS的微缺失。
- 35个ASD相关缺失映射到PTCHD1位点并破坏PTCHD1-AS外显子。
临床怎么用
- PTCHD1-AS缺失可作为ASD遗传风险评估的候选标志物,但尚需临床验证。
- 突触兴奋性异常提示NMDA受体功能可能是该亚型ASD的潜在干预靶点。
局限性
- 研究基于3名ASD患者的iPSC模型,样本量有限。
- 体外iPSC来源神经元不能完全反映体内发育和环路复杂性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Xp22.11 locus that encompasses PTCHD1, DDX53, and the long noncoding RNA PTCHD1-AS is frequently disrupted in male subjects with autism spectrum disorder (ASD), but the functional consequences of these genetic risk factors for ASD are unknown. METHODS: To evaluate the functional consequences of PTCHD1 locus deletions, we generated induced pluripotent stem cells (iPSCs) from unaffected control subjects and 3 subjects with ASD with microdeletions affecting PTCHD1-AS/PTCHD1, PTCHD1-AS/DDX53, or PTCHD1-AS alone. Function of iPSC-derived cortical neurons was assessed using molecular approaches and electrophysiology. We also compiled novel and known genetic variants of the PTCHD1 locus to explore the roles of PTCHD1 and PTCHD1-AS in genetic risk for ASD and other neurodevelopmental disorders. Finally, genome editing was used to explore the functional consequences of deleting a single conserved exon of PTCHD1-AS. RESULTS: iPSC-derived neurons from subjects with ASD exhibited reduced miniature excitatory postsynaptic current frequency and N-methyl-D-aspartate receptor hypofunction. We found that 35 ASD-associated deletions mapping to the PTCHD1 locus disrupted exons of PTCHD1-AS. We also found a novel ASD-associated deletion of PTCHD1-AS exon 3 and showed that exon 3 loss altered PTCHD1-AS splicing without affecting expression of the neighboring PTCHD1 coding gene. Finally, targeted disruption of PTCHD1-AS exon 3 recapitulated diminished miniature excitatory postsynaptic current frequency, supporting a role for the long noncoding RNA in the etiology of ASD. CONCLUSIONS: Our genetic findings provide strong evidence that PTCHD1-AS deletions are risk factors for ASD, and human iPSC-derived neurons implicate these deletions in the neurophysiology of excitatory synapses and in ASD-associated synaptic impairment.
引用
- Ross PJ, Zhang WB, Mok RSF, et al. Synaptic Dysfunction in Human Neurons With Autism-Associated Deletions in PTCHD1-AS. Biol Psychiatry. 2019. PMID: 31540669. doi:10.1016/j.biopsych.2019.07.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。